Presently, Werner Lanthaler occupies the position of Chief Executive Officer of Evotec SE.

He is also on the board of AC Immune SA, argenx SE, Evotec (UK) Ltd. and Topas Therapeutics GmbH (former Chairman-Supervisory Board).

In the past Dr. Lanthaler held the position of Chief Financial Officer of Intercell AG.

Dr. Lanthaler received a doctorate and an undergraduate degree from the University of Vienna and a graduate degree from Harvard University.